S 3758 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
End Veterans Overdose Act of 2026
To direct the Secretary of Veterans Affairs to make opioid overdose rescue medications available to veterans and their caregivers, and for other purposes.
Summary
The End Veterans Overdose Act of 2026 directs the Department of Veterans Affairs to make opioid overdose rescue medications such as naloxone available at VA pharmacies to veterans and their designated caregivers at no charge and without a prescription. Veterans and caregivers receiving the medication must also receive information on proper use. The VA is limited in how it can use information collected in connection with this program, prohibiting use of such information for employment decisions or as evidence of drug use or addiction. The Secretary must report to Congress within two years and annually thereafter on the number of recipients, feasibility of expanding the program to family members or non-VA providers, medication utilization trends, and recommendations for the program. The program aims to provide emergency overdose treatment access to veterans and their caregivers.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Sen. Shaheen, Jeanne [D-NH] (D-NH)
1 cosponsor
- Sen. Crapo, Mike [R-ID] (R-ID)
Actions (3)
- Mar 18, 2026 Committee on Veterans' Affairs. Ordered to be reported with an amendment in the nature of a substitute favorably. · senate
- Feb 2, 2026 Read twice and referred to the Committee on Veterans' Affairs. · senate
- Feb 2, 2026 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Committee action
What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.
Meetings where this bill was on the agenda
Full text
IN THE SENATE OF THE UNITED STATES
February 2, 2026
Mrs. Shaheen (for herself and Mr. Crapo) introduced the following bill; which was read twice and referred to the Committee on Veterans’ Affairs
A BILL
To direct the Secretary of Veterans Affairs to make opioid overdose rescue medications available to veterans and their caregivers, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “End Veterans Overdose Act of 2026”.
SEC. 2. PROVISION OF OPIOID OVERDOSE RESCUE MEDICATIONS BY DEPARTMENT OF VETERANS AFFAIRS TO VETERANS AND THEIR CAREGIVERS.
(a) In General.—The Secretary of Veterans Affairs shall make covered medications available at pharmacies of the Department of Veterans Affairs to any covered veteran or caregiver of a covered veteran at no charge and without a prescription.
(b) Provision of Information.—The Secretary shall ensure that any veteran or caregiver of a covered veteran who receives a covered medication under subsection (a) also receives drug information on the use of such medication.
(c) Limitation on Use of Information.—
(1) In general.—In carrying out this section, the Secretary may only collect the personally identifiable information needed for prescribing covered medication, and any personally identifiable information collected under this section may be used solely for the purpose of delivering, evaluating, and enhancing the quality of health care.
(2) Exclusion.—The Secretary may not use any personally identifiable information collected under this section—
(A) for the purpose of preventing a veteran from employment;
(B) as evidence of a history of drug use; or
(C) as evidence that an individual is an unlawful user of or addicted to any controlled substance.
(d) Report.—
(1) In general.—Not later than two years after the date on which the Secretary first makes covered medications available to covered veterans and the caregivers of covered veterans pursuant to subsection (a), and annually thereafter, the Secretary shall submit to Congress a report on this section.
(2) Elements.—The report required under paragraph (1) shall include each of the following:
(A) The number of covered veterans and caregivers of covered veterans who received covered medications under this section.
(B) An assessment of the feasibility of expanding the authority under this section to provide covered medications to immediate family members of covered veterans.
(C) An assessment of the feasibility of expanding the authority under this section to include non- Department health care providers through which the Secretary furnishes hospital care, medical services, and extended care services to covered veterans under section 1703 of title 38, United States Code.
(D) An assessment of trends in the utilization of covered medications provided under this section.
(E) Any other recommendations of the Secretary with respect to the authority under this section.
(e) Definitions.—In this section:
(1) Caregiver.—The term “caregiver” means—
(A) a family caregiver of a veteran participating in the program of comprehensive assistance for family caregivers under subsection (a) of section 1720G of title 38, United States Code; or
(B) a caregiver of a veteran participating in the program of general caregiver support services under subsection (b) of such section.
(2) Covered medication.—The term “covered medication” means any opioid overdose rescue medication, such as naloxone.
(3) Covered veteran.—The term “covered veteran” has the meaning given that term in section 1703(b) of title 38, United States Code. <all>
Comments